Adrian Rawcliffe
Board Member
Adaptimmune Therapeutics PLC (ADAPY)Board Member
Wave Life Sciences, Inc. (WVE)Equibles does not estimate personal net worth.
Get an email with a short summary when Adaptimmune Therapeutics PLC publishes a filing, an earnings call transcript or a press release.
Get ADAPY alertsAbout Adrian Rawcliffe
Adrian Rawcliffe is recorded as Board Member and CEO at Adaptimmune Therapeutics PLC (ADAPY) and Board Member at Wave Life Sciences, Inc. (WVE). The newest filing on record that lists Adrian Rawcliffe as Board Member and CEO at Adaptimmune Therapeutics PLC (ADAPY) is dated April 25, 2025. The newest filing on record that lists Adrian Rawcliffe as Board Member at Wave Life Sciences, Inc. (WVE) is dated October 14, 2026. The proxy statement of Adaptimmune Therapeutics PLC reports total compensation of $4,215,001 for Adrian Rawcliffe in fiscal 2021, including a base salary of $617,050. Disclosed compensation is on record for 3 fiscal years. Adaptimmune Therapeutics PLC is classified in the Biotechnology industry within the Healthcare sector. Wave Life Sciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Adaptimmune Therapeutics PLC includes David M. Mott (Chairman), Christopher Hill (CFO), William Bertrand (COO) and 7 others.
Affiliation history
-
Current
Start not stated–present
Last confirmed April 25, 2025
-
Current
Start not stated–present
Last confirmed April 25, 2025
-
Current
Start not stated–present
Last confirmed October 14, 2026
Company network
Leadership on record at Adaptimmune Therapeutics PLC
- David M. Mott Chairman
- Christopher Hill CFO
- William Bertrand COO
- Ali Behbahani Board Member
- Andrew Allen Board Member
- Andrew Allen, MD, PhD Board Member
- Andrew R. Allen Board Member
- Dr Priti Hegde Board Member
- Garry E. Menzel Board Member
- Garry Menzel Board Member
Leadership on record at Wave Life Sciences, Inc.
- Paul Bolno CEO, Board Member
- Christian Henry Chairman
- David Gaiero CFO, Chief Accounting Officer
- Kyle Moran CFO
- Chandra Vargeese CTO
- Aik Na Tan Board Member
- Gregory L. Verdine Board Member
- Heidi L. Wagner Board Member
- Ken Takanashi Board Member
- Mark H.N. Corrigan Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Adaptimmune Therapeutics PLC (ADAPY) | Chief Executive Officer | $617,050 | $4,215,001 |
| 2020 | Adaptimmune Therapeutics PLC (ADAPY) | Chief Executive Officer | $574,000 | $2,701,602 |
| 2019 | Adaptimmune Therapeutics PLC (ADAPY) | Chief Executive Officer | $500,481 | $2,155,042 |
Recent activity
No call appearances or filed executive changes recorded yet.